| Name | Title | Contact Details |
|---|---|---|
Shelley Brinkley |
Senior Director, Talent | Profile |
Gerry Glennon |
Vice President of Global Supply Chain | Profile |
Rose-Marie Nelson |
EVP, Talent Acquisition, Benefits and | Profile |
Rose-Marie Nelson |
Chief Human Resources Officer | Profile |
Shelley Brinkley |
Director Talent Acquisition | Profile |
Ohr Pharmaceutical, Inc. (OHRP) is an ophthalmology research and development company. The company`s lead product, Squalamine (OHR-102), is currently being studied as an eye drop formulation in several company sponsored and investigator sponsored Phase II clinical trials for various back-of-the-eye diseases, including the wet form of age-related macular degeneration, retinal vein occlusion, diabetic macular edema, and proliferative diabetic retinopathy. In addition, Ohr has a sustained release micro fabricated micro-particle ocular drug delivery platform with several preclinical drug product candidates in development for glaucoma, steroid-induced glaucoma, ocular allergies, and protein drug delivery.
Avecia Biotechnology is a Milford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
natures sunshine products is a Provo, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cynapsus Therapeutics Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Irix Pharmaceuticals is a Florence, SC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.